U
ACH

UBS’s Accendra Health ACH Stock Holding History

UBS’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Hold
100
– – ﹤0.01% 9803
2014
Q2 		$3K Buy
+100
New +$3.43K ﹤0.01% 9840

Other funds holding ACH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's ACH Position: Q3 2014 in Review

UBS reduced its Accendra Health (ACH) stake by 64% in Q3 2014, selling an estimated $201K and leaving 3,358 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #5879.

UBS first reported a position in ACH in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.8M in Q1 2014. 224 funds tracked by Wall St. Rank hold ACH as of Q3 2014.

  • UBS held 3,358 shares of Accendra Health worth $110K as of Q3 2014.
  • UBS sold 5,915 Accendra Health shares in Q3 2014, an estimated $201K.
  • Accendra Health made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5879 holding.
  • UBS first reported a position in Accendra Health in Q2 2013 and has held it in 6 quarters since.
  • UBS's Accendra Health position peaked at $2.8M in Q1 2014.
  • 224 funds tracked by Wall St. Rank held Accendra Health as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.